does semaglutide shrink your heart and the Heart: clinical insights from the SELECT Trial Heart disease: Semaglutide may reduce

The transdermal design allows ingredients to be absorbed gradually through the skin, offering a simple, non-messy alternative for those who prefer wearable wellness solutions

Premiums are shifting, and the government contribution varies

Outlook for 2030 By 2030, obesity pharmacotherapy will likely be divided into three dominant segments: oral therapies (Orforglipron), monthly injectables (Berobenatide and MariTide), and high-efficacy multi-agonists (Retatrutide, Amycretin, and CagriSema)

Mounting research suggests GLP-1 drugs, which are used to treat diabetes and obesity, may one day help people with alcohol use disorder

Another flurry of media attention occurred as the drug became available, with news that supply couldn't keep up with demand

Currently used antidepressant drugs, which mostly target brain monoaminergic neurotransmission, have limited clinical efficacy